Skip to content

Cost-effectiveness of package 3 versus package 2 of the BeweegKuur in the prevention and treatment of overweight

Cost-effectiveness of package 3 (a supervised physical training and nutrition program) versus package 2 of the BeweegKuur a combined lifestyle intervention in the prevention and treatment of overweight

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN46574304
Enrollment
600
Registered
2011-02-10
Start date
2010-08-01
Completion date
Unknown
Last updated
2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obesity Nutritional, Metabolic, Endocrine Obesity

Interventions

Experimental program is package 3 of the BeweegKuur consisting of a physical activity and dietary program. Control program is package 2 of the BeweegKuur consisting of a physical activity and dietary

Sponsors

The Netherlands Organization for Health Research and Development (ZonMw) (Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults with a weight-related health risk 2. Have an inactive lifestyle (Dutch norm Healthy Exercise: 30 minutes moderate physical activity for at least 5 days per week) 3. Motivated for behavioral change 4. Willing to participate after having read the informed consent information 5. Body mass index (BMI) between 25 - 30 kg/m2 combined with a large waist circumference (men greater than 102 cm, women greater than 88 cm) with comorbidity (cardiovascular disease and/or diabetes mellitus II, arthrosis and sleep apnoea) 6. BMI between 30 - 35 kg/m2 combined with a normal or large waist circumference with comorbidity 7. BMI between 35 - 40 kg/m2 combined with a normal or large waist circumference with risk factors for cardiovascular disease or diabetes mellitus II and without other comorbidity

Exclusion criteria

Exclusion criteria: 1. BMI less than 25 kg/m2 2. BMI of 25 - 30 kg/m2 combined with normal waist circumference 3. BMI of 35 - 40 kg/m2 combined with comorbidity (cardiovascular disease and/or diabetes mellitus II, arthrosis and sleep apnoea) 4. BMI of greater than 40 kg/m2 5. Impairments that prevent from participating in the BeweegKuur (according to the GP)

Design outcomes

Primary

MeasureTime frame
Moderate to vigorous physical activity (MVPA) in minutes per week. This is measured by means of: 1. Activity monitor at baseline, and at one year and two years after the start of the intervention 2. Self administered questionnaire International Physical Activity Questionnaire (IPAQ) at baseline, six months, twelve months, 18 months and 24 months

Secondary

MeasureTime frame
1. Dietary habits (short version of the ENVET) at baseline, six months, twelve months, 18 months and 24 months 2. Quality of life (EQ6-D), medication, side effects, direct and indirect costs, at baseline and every three months from baseline until 2 years of follow-up 3. Health risk, e.g. waist circumference (cm), body composition (body mass in kg, fat and fat free mass in %), diastolic blood pressure (DPB) (mmHg), systolic blood pressure (SBP) (mmHg), resting heart rate, blood values, i.e. fasting glucose (mmol/L), HbA1c (% or mmol/L), total cholesterol (mmol/L), HDL (mmol/L), triglycerides (mmol/L) and creatinin (micromol/L) and physical fitness (Astrand test, Valk neuropathy test, Timed Up and Go Test) at baseline, at one year and two years after start of the program

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 28, 2026